0.6768
4.95%
0.0319
Handel nachbörslich:
.67
-0.0068
-1.00%
Finanzdaten der Bioxcel Therapeutics Inc-Aktie (BTAI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
54.79%
0.582
|
0.376 | 0.341 | 0.457 | 0.206 |
Cost Of Revenue |
88.80%
0.08
|
0.714 | 0.512 | 0.026 | 0.009 |
Gross Profit |
248.52%
0.502
|
-0.338 | -0.171 | 0.431 | 0.197 |
Operating Expenses
|
26.25%
24.66
|
19.54 | 48.13 | 52.84 | 51.40 |
Interest Income/Expense |
5.01%
3.607
|
3.435 | 3.252 | 3.259 | 3.367 |
Benefits Costs and Expenses |
20.95%
27.37
|
22.63 | 48.64 | 52.87 | 53.00 |
Costs And Expenses |
22.19%
24.75
|
20.25 | 48.64 | 52.87 | 51.40 |
Operating Income/Loss |
21.57%
-24.16
|
-19.88 | -48.30 | -52.41 | -51.20 |
Income/Loss From Continuing Operations Before Tax |
20.38%
-26.79
|
-22.26 | -48.30 | -53.52 | -52.80 |
Income/Loss From Continuing Operations After Tax |
20.38%
-26.79
|
-22.26 | -50.49 | -53.52 | -52.80 |
Net Income/Loss
|
20.38%
-26.79
|
-22.26 | -50.49 | -53.52 | -52.80 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
29,869%
30.87
|
0.103 | 29.27 | 29.19 | 28.62 |
Diluted Average Shares |
29,869%
30.87
|
0.103 | 29.27 | 29.19 | 0.0286 |
Basic Earnings Per Share |
16.00%
-0.87
|
-0.75 | -1.72 | -1.83 | -1.84 |
Diluted Earnings Per Share |
16.00%
-0.87
|
-0.75 | -1.72 | -1.83 | -1.84 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):